| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $5.4B | $5.0B | $3.7B | $3.3B | $3.1B | $2.9B |
| Cost of Revenue | — | $2.4B | $2.6B | $2.5B | $2.0B | $1.7B | $1.6B | $1.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.5B | $0.5B | $0.4B | $-0.0B | $0.4B | $0.2B | $0.1B | $0.1B |
| Net Income | $0.4B | $0.2B | $0.2B | $-0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $6.09 | $2.77 | $2.13 | $-3.10 | $3.39 | $1.82 | $1.67 | $1.36 |
| EPS (Diluted) | $6.08 | $2.76 | $2.13 | $-3.10 | $3.39 | $1.82 | $1.67 | $1.36 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.4B | $12.0B | $11.9B | $13.2B | $12.8B | $8.7B | $8.2B | $7.4B |
| Current Assets | $1.2B | $1.5B | $1.9B | $3.7B | $1.6B | $0.9B | $0.9B | $0.8B |
| Cash & Equivalents | $0.6B | $0.4B | $0.1B | $0.1B | $0.2B | $0.1B | $0.0B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.9B | $1.8B | $1.7B | $3.4B | $3.1B | $0.9B | $1.1B | $0.9B |
| Stockholders' Equity | $4.0B | $3.5B | $3.3B | $3.1B | $3.0B | $2.7B | $2.5B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $1.4B | $0.5B | $0.4B | $0.1B | $0.6B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.0B | $-0.9B | $0.2B | $-0.8B | $-3.0B | $-0.8B | $-1.0B | $-1.0B |
| Capital Expenditures | $0.8B | $0.9B | $0.9B | $0.9B | $0.7B | $0.8B | $0.9B | $0.8B |
| Financing Cash Flow | $-0.3B | $-0.2B | $-0.7B | $0.4B | $3.1B | $0.2B | $0.4B | $0.5B |